Healing, discovery and hope happen when we dream and work in concert with each other. From restoring sound and sight to advancing brain health, #CUAnschutz is leading research that brings new hope to patients everywhere.
✨ Never dream alone. https://t.co/zfv0hFaA12
Peptide injectables are gaining attention online, but many have not undergone the testing required for FDA approval. A #CUAnschutz medical toxicologist discusses the science and safety concerns surrounding these compounds. 👇
https://t.co/xeQnizTC6v
A new drug developed by #CUAnschutz researchers may offer a different approach to treating alcohol use disorder. The drug, Nezavist, works to target gut-brain communication rather than acting directly on the brain. 💊
https://t.co/f1O6ZTv0ZD
What an incredible weekend at the 2026 SPS Symposium! Thank you to every attendee — in person and virtual — and a huge shoutout to Dr. Amanda Piquet and the team at @CUAnschutz for hosting and volunteering. We are so grateful! #SPSRF#StiffPersonSyndrome
An 80% cut to syringe program funding could mean 39,600 additional deaths in five years among US people who inject drugs, including 15,600 from overdose, according to modeled projections. @cuanschutz@jamanetworkopen https://t.co/uER4CclBiY
After nearly a decade unable to walk without assistance, Colorado resident Lynn Montgomery-Haga is walking freely again.
Lynn was the first patient enrolled in a #CUAnschutz CAR T-cell trial that could transform treatment for stiff person syndrome.
🔗: https://t.co/O0t7tVkLzA
Researchers at @CUAnschutz are working to better understand & prevent type 1 diabetes. Read how the campus’s renowned Barbara Davis Center for Diabetes is advancing research to slow disease progression and guide future therapies.
https://t.co/xAklZOSS8Q
Not all post-amputation pain is the same. New CU Anschutz study shows separating pain types can boost comfort, mobility & recovery for amputees. Learn how prosthetic design impacts pain: https://t.co/bNzdewIdDA #Amputation#PainResearch#Rehab#Prosthetics
The U.S. News & World Report has released its 2026-2027 Best Global Universities rankings. We're proud of our oncologists for their tireless efforts in the fight against cancer. This ranking of @CUAnschutz reflects their work: https://t.co/tgzw9y568r
Our @CULymphoma lead Dr. @mana1981 contributed to a multicenter study, now published @BloodCancerJnl, describing outcomes of MCL after BR and BTK inhibitors. #lymsm#tcellrx
https://t.co/3cBvGuIkQ9
Bemotrizinol is the first new ingredient approved by the FDA for sunscreens in two decades. 🌞 #CUAnschutz dermatologist Theresa Pacheco, MD, shares how this chemical sunscreen works differently to block the sun's rays.
https://t.co/LjXUIBo3YG
50+ future residents and countless possibilities ahead 🤩
We're excited to officially welcome our newest residents to the CU Anschutz Internal Medicine family! We're looking forward to supporting this talented group as they learn, grow, and begin the next chapter of their medical careers. 🌟💙
🩺 #mCRC care is officially past the era of “treat first, sort it out later.”
At #ASCO2026, Dr. Lieu (@CUAnschutz ) made the case: early biomarker testing+upfront personalized therapy=better outcomes. Full stop.
Watch▶️ https://t.co/M9ovlR1qNx
#OncTwitter#CRC
#CUAnschutz researchers have published a proof-of-concept study demonstrating that injectable #semaglutide may offer meaningful reproductive benefits for women with polyendocrine metabolic ovarian syndrome (#PMOS), formerly known as #PCOS https://t.co/XCdcu0dix7
A #CUAnschutz gene therapy study is showing positive results for patients with urea cycle disorder—a rare disease that can lead to brain damage and even death. 🧠 Researchers will likely move forward to study infants and children next.
https://t.co/An8u8ZEQd8
Research from #CUAnschutz suggests a father’s stress before conception may influence a child’s growth. Scientists found that stress can change tiny molecules in sperm that may help shape development from the earliest stages of life.
🔗 Learn more: https://t.co/YpgkUzWdmI
It's #NationalCancerSurvivorsDay. In this article, Jennifer Diamond, MD, discusses the roles of both clinical trial researchers and participants and how they affect the rise in cancer survivorship: https://t.co/lpti8xGPnS
A new study by our midwives in the Journal of Midwifery & Women's Health examines factors that may increase the risk of a C-section and the important role midwives play in providing supportive, evidence-based care. https://t.co/669XMUDsOh
@ACNMmidwives@cuanschutz
Pancreatic cancer remains one of the most difficult cancers to treat. #CUAnschutz oncologist Christopher Lieu, MD, spoke with @ConversationUS about a new drug that has nearly doubled overall survival in patients with advanced pancreatic cancer: https://t.co/iBDc9PvHJD.
The Rocky Mountain MS Center at #CUAnschutz is home to one of the largest multiple sclerosis research programs in the world.
From groundbreaking discoveries to clinical trials and emerging therapies, our researchers are advancing care and improving lives: https://t.co/3QFYzN6ivQ
Congratulations to Ludeman Center Associate Director Jane Reusch, MD, for being recognized at the 2026 Distinguished Faculty Professionalism Awards at @CUAnschutz for her research on diabetes metabolism, exercise intolerance & women’s health. Read more.
https://t.co/iHuXB0MRtT